Drug Type Antibody drug conjugate (ADC) |
Synonyms anti-endoglin antibody drug conjugates(ImmunoGen), huRH-105-SMCC-DM1, huRH-105-sSDB-DM4 + [1] |
Target |
Action inhibitors |
Mechanism ENG inhibitors(endoglin inhibitors), Tubulin inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Preclinical | United States | - |